Ignite Creation Date:
2024-10-26 @ 3:35 PM
Last Modification Date:
2024-10-26 @ 3:35 PM
Study NCT ID:
NCT06510582
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-06-28
Brief Title:
Chronic Subdural Hematoma Treatment With Intra-Arterial Bevacizumab Injection
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Chronic Subdural Hematoma Treatment With Avastin Bevacizumab Intra-Arterial Injection A Non-Randomized Open-Label Phase 12 Clinical Trial
Status:
RECRUITING
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
CHAI
Brief Summary:
The goal of this clinical trial is to test whether infusing bevacizumab into the middle meningeal arteries can be used to treat chronic subdural hematomas cSDH
The main questions it aims to answer are
Is bevacizumab infusion safe in cSDH patients
Is bevacizumab infusion effective in treating cSDH
The main questions it aims to answer are
Is bevacizumab infusion safe in cSDH patients
Is bevacizumab infusion effective in treating cSDH
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None